Transcatheter Arterial Chemoembolization

What is Transcatheter Arterial Chemoembolization?

Transcatheter arterial chemoembolization (TACE) is a minimally invasive, targeted treatment for some advanced tumors in the liver that doctors can't remove surgically.

Doctors use TACE alone or with other therapies to treat your cancer, as long as your liver functions well.

This treatment works because the liver has two different blood supplies. The portal vein feeds healthy cells, while cancer cells get blood from the hepatic artery.

During TACE, doctors thread a catheter through an artery in your groin to the tumor site. They then embolize, or block, the hepatic artery's blood supply to the tumor and dispense chemo drugs through the catheter.

TACE allows a powerful chemo solution to be in contact with the tumor for a long time. Since the chemo remains at the tumor site, it doesn't kill healthy cells nearby. At the same time, embolization starves the tumor of the blood, oxygen, and nutrients it needs to grow.


Cancers We Treat With TACE

Your treatment depends on your cancer type and location. Your doctor will discuss your treatment options with you.

TACE may be effective for primary liver cancer, or cancer that starts in the liver.

It also works for other cancers that have spread to the liver, such as:


What Can I Expect From Transcatheter Arterial Chemoembolization?

Make an Appointment For TACE Treatment Today

UPMC Hillman Cancer Center provides the highest level of care to more than 110,000 people each year.

Our cancer surgeons use the latest, minimally invasive techniques to treat your cancer. And, our results are often better than other leading cancer centers, increasing survivorship.

To learn more about TACE and if it's an option for you, contact the David C. Koch Regional Perfusion Cancer Therapy Center. Or, call UPMC Hillman Cancer Center at 412-692-2852.